Patent details
EP2985031 Title: USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF VARIOUS DISEASES
Basic Information
- Publication number:
- EP2985031
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP150009942
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF VARIOUS DISEASES
- French Title of Invention:
- UTILISATION DE PEPTIDES PERMÉABLES AUX CELLULES DE LA VOIE DE TRANSDUCTION DU SIGNAL JNK POUR LE TRAITEMENT DE DIVERSES MALADIES
- German Title of Invention:
- VERWENDUNG VON ZELLDURCHLÄSSIGEN PEPTIDHEMMERN DES JNK-SIGNALTRANSDUKTIONSWEGES ZUR BEHANDLUNG VERSCHIEDENER KRANKHEITEN
- SPC Number:
Dates
- Filing date:
- 02/06/2009
- Grant date:
- 12/04/2017
- EP Publication Date:
- 17/02/2016
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 12/04/2017
- EP B1 Publication Date:
- 12/04/2017
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 02/06/2017
- Expiration date:
- 02/06/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 12/04/2017
- Name:
- Xigen Inflammation Ltd.
- Address:
- Arch. Makariou III 195 Neocleous House, 3030 Limassol, Cyprus (CY)
Inventor
- Name:
- Bonny, Christophe
- Address:
- Switzerland (CH)
Priority
- Priority Number:
- PCT/EP2008/004341
- Priority Date:
- 30/05/2008
- Priority Country:
- World Intellectual Property Office (WIPO) (WO)
Classification
- IPC classification:
- A61K 38/01; A61K 38/03; A61K 38/04; A61P 9/00; A61P 11/00; A61P 17/00; A61P 25/00; A61P 31/12; A61P 37/00;
Publication
European Patent Bulletin
- Issue number:
- 201715
- Publication date:
- 12/04/2017
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 30/10/2017 | Outgoing Correspondence | 1 |